92 related articles for article (PubMed ID: 22753765)
1. LXR agonists and ABCG1-dependent cholesterol efflux in MCF-7 breast cancer cells: relation to proliferation and apoptosis.
El Roz A; Bard JM; Huvelin JM; Nazih H
Anticancer Res; 2012 Jul; 32(7):3007-13. PubMed ID: 22753765
[TBL] [Abstract][Full Text] [Related]
2. Synthetic High-Density Lipoprotein-Mediated Targeted Delivery of Liver X Receptors Agonist Promotes Atherosclerosis Regression.
Guo Y; Yuan W; Yu B; Kuai R; Hu W; Morin EE; Garcia-Barrio MT; Zhang J; Moon JJ; Schwendeman A; Eugene Chen Y
EBioMedicine; 2018 Feb; 28():225-233. PubMed ID: 29361501
[TBL] [Abstract][Full Text] [Related]
3. Modulation of ABCA1 by an LXR agonist reduces β-amyloid levels and improves outcome after traumatic brain injury.
Loane DJ; Washington PM; Vardanian L; Pocivavsek A; Hoe HS; Duff KE; Cernak I; Rebeck GW; Faden AI; Burns MP
J Neurotrauma; 2011 Feb; 28(2):225-36. PubMed ID: 21175399
[TBL] [Abstract][Full Text] [Related]
4. CYP27A1 inhibits bladder cancer cells proliferation by regulating cholesterol homeostasis.
Liang Z; Chen Y; Wang L; Li D; Yang X; Ma G; Wang Y; Li Y; Zhao H; Liang Y; Niu H
Cell Cycle; 2019 Jan; 18(1):34-45. PubMed ID: 30563407
[TBL] [Abstract][Full Text] [Related]
5. LIM-only protein FHL2 is a positive regulator of liver X receptors in smooth muscle cells involved in lipid homeostasis.
Kurakula K; Sommer D; Sokolovic M; Moerland PD; Scheij S; van Loenen PB; Koenis DS; Zelcer N; van Tiel CM; de Vries CJ
Mol Cell Biol; 2015 Jan; 35(1):52-62. PubMed ID: 25332231
[TBL] [Abstract][Full Text] [Related]
6. Flindissone, a Limonoid Isolated from
Resetar M; Tietcheu Galani BR; Tsamo AT; Chen Y; Schachner D; Stolzlechner S; Mawouma Pagna JI; Beniddir MA; Kirchmair J; Dirsch VM
J Nat Prod; 2023 Aug; 86(8):1901-1909. PubMed ID: 37526502
[TBL] [Abstract][Full Text] [Related]
7. Menin Maintains Cholesterol Content in Colorectal Cancer via Repression of LXR-Mediated Transcription.
Nyul TE; Beyries K; Hojnacki T; Glynn R; Paulosky KE; Gedela A; Majer A; Altman L; Buckley KH; Feng Z; Sun K; Peng Z; Tobias JW; Hua X; Katona BW
Cancers (Basel); 2023 Aug; 15(16):. PubMed ID: 37627154
[TBL] [Abstract][Full Text] [Related]
8. LXR agonism for CNS diseases: promises and challenges.
Zhang R; Wuerch E; Yong VW; Xue M
J Neuroinflammation; 2024 Apr; 21(1):97. PubMed ID: 38627787
[TBL] [Abstract][Full Text] [Related]
9. 27-Hydroxycholesterol links hypercholesterolemia and breast cancer pathophysiology.
Nelson ER; Wardell SE; Jasper JS; Park S; Suchindran S; Howe MK; Carver NJ; Pillai RV; Sullivan PM; Sondhi V; Umetani M; Geradts J; McDonnell DP
Science; 2013 Nov; 342(6162):1094-8. PubMed ID: 24288332
[TBL] [Abstract][Full Text] [Related]
10. The anti-proliferative and pro-apoptotic effects of the trans9, trans11 conjugated linoleic acid isomer on MCF-7 breast cancer cells are associated with LXR activation.
El Roz A; Bard JM; Huvelin JM; Nazih H
Prostaglandins Leukot Essent Fatty Acids; 2013 Apr; 88(4):265-72. PubMed ID: 23375583
[TBL] [Abstract][Full Text] [Related]
11. Liver X receptor as a drug target for the treatment of breast cancer.
Wu Y; Yu DD; Yan DL; Hu Y; Chen D; Liu Y; Zhang HD; Yu SR; Cao HX; Feng JF
Anticancer Drugs; 2016 Jun; 27(5):373-82. PubMed ID: 26872310
[TBL] [Abstract][Full Text] [Related]
12. Cholesterol and breast cancer pathophysiology.
Nelson ER; Chang CY; McDonnell DP
Trends Endocrinol Metab; 2014 Dec; 25(12):649-55. PubMed ID: 25458418
[TBL] [Abstract][Full Text] [Related]
13. Liver X receptors in lipid metabolism: opportunities for drug discovery.
Hong C; Tontonoz P
Nat Rev Drug Discov; 2014 Jun; 13(6):433-44. PubMed ID: 24833295
[TBL] [Abstract][Full Text] [Related]
14. Oxysterols in cancer cell proliferation and death.
de Weille J; Fabre C; Bakalara N
Biochem Pharmacol; 2013 Jul; 86(1):154-60. PubMed ID: 23500545
[TBL] [Abstract][Full Text] [Related]
15. Uncoupling nuclear receptor LXR and cholesterol metabolism in cancer.
Bovenga F; Sabbà C; Moschetta A
Cell Metab; 2015 Apr; 21(4):517-26. PubMed ID: 25863245
[TBL] [Abstract][Full Text] [Related]
16. Convergent multi-miRNA targeting of ApoE drives LRP1/LRP8-dependent melanoma metastasis and angiogenesis.
Pencheva N; Tran H; Buss C; Huh D; Drobnjak M; Busam K; Tavazoie SF
Cell; 2012 Nov; 151(5):1068-82. PubMed ID: 23142051
[TBL] [Abstract][Full Text] [Related]
17. Macrophage apolipoprotein E and proliferation of MCF-7 breast cancer cells: role of LXR.
El Roz A; Bard JM; Valin S; Huvelin JM; Nazih H
Anticancer Res; 2013 Sep; 33(9):3783-9. PubMed ID: 24023310
[TBL] [Abstract][Full Text] [Related]
18. Liver × receptor ligands disrupt breast cancer cell proliferation through an E2F-mediated mechanism.
Nguyen-Vu T; Vedin LL; Liu K; Jonsson P; Lin JZ; Candelaria NR; Candelaria LP; Addanki S; Williams C; Gustafsson JÅ; Steffensen KR; Lin CY
Breast Cancer Res; 2013 Jun; 15(3):R51. PubMed ID: 23809258
[TBL] [Abstract][Full Text] [Related]
19. 5,6-Epoxy-cholesterols contribute to the anticancer pharmacology of tamoxifen in breast cancer cells.
Segala G; de Medina P; Iuliano L; Zerbinati C; Paillasse MR; Noguer E; Dalenc F; Payré B; Jordan VC; Record M; Silvente-Poirot S; Poirot M
Biochem Pharmacol; 2013 Jul; 86(1):175-89. PubMed ID: 23500540
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic value of the Vesikari Scoring System for predicting the viral or bacterial pathogens in pediatric gastroenteritis.
Shim DH; Kim DY; Cho KY
Korean J Pediatr; 2016 Mar; 59(3):126-31. PubMed ID: 27186219
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
